Related Experiment Video
Updated: Dec 23, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk
Mohsen Saravani1,2, Hossein Shahraki-Ghadimi1,3, Rostam Maruei-Milan2
1Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Abstract:
The systemic lupus erythematosus (SLE) is an autoimmune disease, leading to inflammatory response and systemic consequences. The mammalian target of rapamycin (mTOR) is a therapeutic target for autoimmune diseases like SLE. The aim of this study was to evaluate the effects of the mTOR rs2295080 and rs2536 polymorphisms and AKT1 rs2494732 gene polymorphism on SLE development. 2 ml of peripheral blood was collected from 165 SLE patients and 170 controls in EDTA-containing tubes. The salting-out and PCR-RFLP methods were used for DNA extraction and genotype analysis, respectively. Based on the regression analysis, the frequency of TT genotype of mTOR rs2295080 polymorphism was significantly higher in the case group than that of the control group, with a 2.6-fold increased risk of SLE. There was also a significant difference between the two groups in terms of allelic distribution. No statistically significant association was found between The AKT1 rs2494732 and mTOR rs2536 polymorphisms and SLE development. Our results showed that the TT genotype and T allele of mTOR rs2295080 polymorphism were risk factors for developing SLE. However, there was no significant association between mTOR rs2536 and AKT1 rs2494732 polymorphisms and the SLE risk.
Insights
The TT genotype and T allele of the mammalian target of rapamycin (mTOR) rs2295080 polymorphism significantly increase systemic lupus erythematosus (SLE) risk. Other tested mTOR and AKT1 gene variations showed no association with SLE development.
Area of Science:
- Immunogenetics
- Molecular Biology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with significant systemic inflammatory consequences.
- The mammalian target of rapamycin (mTOR) pathway is recognized as a potential therapeutic target for autoimmune disorders, including SLE.
- Genetic variations in key molecular pathways may influence individual susceptibility to SLE.
Purpose of the Study:
- To investigate the association between specific polymorphisms in the mTOR (rs2295080, rs2536) and AKT1 (rs2494732) genes and the risk of developing SLE.
- To identify potential genetic risk factors that could contribute to SLE pathogenesis.
Main Methods:
- Peripheral blood samples were collected from 165 SLE patients and 170 healthy controls.
- DNA was extracted using the salting-out method.
- Genotyping and analysis of mTOR rs2295080 and rs2536, and AKT1 rs2494732 polymorphisms were performed using the PCR-RFLP technique.
Main Results:
- The TT genotype of the mTOR rs2295080 polymorphism was found at a significantly higher frequency in SLE patients compared to controls.
- Individuals with the TT genotype of mTOR rs2295080 exhibited a 2.6-fold increased risk of developing SLE.
- A significant difference in allelic distribution for mTOR rs2295080 was observed between the patient and control groups.
- No statistically significant association was detected between the mTOR rs2536 and AKT1 rs2494732 polymorphisms and SLE development.
Conclusions:
- The TT genotype and the T allele of the mTOR rs2295080 polymorphism are identified as significant risk factors for developing SLE.
- The studied polymorphisms in mTOR rs2536 and AKT1 rs2494732 do not appear to be associated with SLE risk in the studied population.
- These findings highlight the role of specific mTOR genetic variations in SLE susceptibility, suggesting potential avenues for further research.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...